Jozef Madzo to Neoplasm, Residual
This is a "connection" page, showing publications Jozef Madzo has written about Neoplasm, Residual.
Connection Strength
0.278
-
Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study. Cancer. 2003 Jan 01; 97(1):105-13.
Score: 0.205
-
TEL/AML 1 real-time quantitative reverse transcriptase PCR can complement minimal residual disease assessment in childhood ALL. Leukemia. 2005 Jul; 19(7):1296-7.
Score: 0.061
-
Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry. Leukemia. 2002 Jul; 16(7):1381-9.
Score: 0.012